Through NICCRAT, we are supporting capacity building of Indonesian researchers and clinicians in the field of pathology and molecular diagnostic

by | Apr 12, 2020 | News & Events

PT. PathGen Diagnostik Teknologi is a spinoff of NICCRAT (Nottingham-Indonesia Collaboration for Clinical Research and Training) initiative, launched in early 2019 by our CEO, Susanti, and her supervisor in Nottingham, the renowned UK pathologist, Prof. Mohammad Ilyas.

NICCRAT is a research and capacity building partnership between the University of Nottingham (UoN), UK and various institutions in Indonesia including Indonesia Institute of Science (Lembaga Ilmu Pengetahuan Indonesia/ LIPI), Stem Cell and Cancer Institute of Kalbe Farma, Tbk., and some medical, pharmacy and health science faculties in various universities in Indonesia, including Universitas Gadjah Mada (UGM), Universitas YARSI, Universitas Hassanudin (UNHAS), Universitas Sriwijaya (UNSRI) and the network of Univeristas Muhammadiyah.

To date, as consortium, NICCRAT has contributes to several capacity building activities both in UK and Indonesia. In March 2019, facilitated by Indonesia Ministry of Research and Higher Education (Kementerian Riset, Teknologi dan Pendidikan Tinggi/RISTEKDIKTI) though BIMTEK (Bimbingan Teknis Scheme) and Asia Business Center of University of Nottingham, NICCRAT delivered an inaugural workshop on “Cancer Precision Medicine” in the Faculty of Medicine, Nursing and Health Science of UGM, Jogjakarta. This event  was opened by Prof. Ali Gufron Mukti, the Director General of Higher Education of KEMENRISTEKDIKTI. In addition, Prof Mohammad Ilyas and Dr. Abhik Mukherjee also delivered satellite guest lectures at the Department of Anatomical Pathology of UGM and Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto (UMP).

In September 2019, the Molecular Pathology Research Group of UoN led by Prof. Ilyas hosted 10 Indonesian researchers and clinicians from LIPI, UGM, UMP and Universitas Indonesia (UI) and delivered a bespoke 4-weeks trainings of “In-depth Training on Molecular Diagnostic for Precision Medicine: Development and Clinical Applications”. The Indonesian delegates was led by Dr. Wien Kusharyoto and funded by RISTEKDIKTI through Research and Innovation in Science and Technology Project (Riset-Pro) scheme.

On 6-7 December 2019, the team from UoN again visited Indonesia to deliver Pathology Masterclass the Pathology Masterclass in Jogjakarta with the theme of “Diagnostic Pathology of The Gastrointestinal Tract, Liver and Pancreas: The Essential of Reporting and Recent Updates”. Attended by about 80 clinicians from all over Indonesia, the masterclass was jointly organised with the Department of Anatomical Pathology, Faculty of Medicine, Public Health and Nursing at UGM. Similar to the BIMTEK, the masterclass was opened by Prof. Ali Gufron Mukti as the Director General of Higher Education of KEMENRISTEK DIKTI.

This visit to Indonesia also marked the initiation of INDiPath (Indonesia-Nottingham Digital Pathology) network. Facilitated by the low-cost technology developed by IPAI, an artificial intelligence start-up company based in Jordan, led by Dr. Michael Al-Oudat. This project will digitally connect the pathology department in Nottingham with partners from three different islands of Indonesia, including Univeristas Gadjah Mada (Java), Univeristas Sriwijaya (Sumatra) and Univeristas Hassanudin (Sulawesi). The network will harness the emerging field of digital pathology for education and research in Indonesia

During this visit on December 2019, Professors Ilyas and team has also attended meeting and discussed further collaboration with Univeristas YARSI and Indonesia Cancer Foundation, in addition to the established partners such as Univeristas Gadjah Mada, Univeristas Muhammadiyah Purwokerto, Indonesia Institute of Science, and Stem Cell and Cancer Institute of Kalbe Farma, Ltd.

So far, NICCRAT has hit the reasonable milestones in fostering the research and training collaborations with counterparts in Indonesia from many academic and research institutions.